US$ 22.73
fda warning letter bpc-157 peptide unapproved drug In a major policy shift, the U.S. Food and Administration is reconsidering restrictions on several controversial peptides, including trending compounds like and Melanotan II. The move comes as demand for “ FDA Targets GLP-1 and Peptide
Description
Theoretical and route-specific risks FDA's 2024 review specifically flagged that no published human exposure data exists for the subcutaneous, transdermal, or intranasal routes that compounding pharmacies have offered

First described back in the 1950s, about 1 in 10 people erupt in acne within days, or even just within hours of getting an injection of vitamin B12, which then disappears rapidly when you stop injecting them

A phase 3 trial found adding Keytruda increases median survival to 17.3 months

Sourander, Andre, et al